[HTML][HTML] Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with …

A Hasegawa, M Murata, T Fujikawa, K Katagiri… - PLoS …, 2023 - journals.plos.org
A small proportion of human T-cell leukemia virus type-1 (HTLV-1)-infected individuals
develop adult T-cell leukemia/lymphoma, a chemotherapy-resistant lymphoproliferative …

Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL …

A Hasegawa, M Murata, T Fujikawa… - PLoS …, 2023 - pubmed.ncbi.nlm.nih.gov
A small proportion of human T-cell leukemia virus type-1 (HTLV-1)-infected individuals
develop adult T-cell leukemia/lymphoma, a chemotherapy-resistant lymphoproliferative …

Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL …

A Hasegawa, M Murata, T Fujikawa… - PLoS …, 2023 - search.ebscohost.com
A small proportion of human T-cell leukemia virus type-1 (HTLV-1)-infected individuals
develop adult T-cell leukemia/lymphoma, a chemotherapy-resistant lymphoproliferative …

[HTML][HTML] Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with …

A Hasegawa, M Murata, T Fujikawa, K Katagiri… - PLOS …, 2023 - ncbi.nlm.nih.gov
A small proportion of human T-cell leukemia virus type-1 (HTLV-1)-infected individuals
develop adult T-cell leukemia/lymphoma, a chemotherapy-resistant lymphoproliferative …

Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL …

A Hasegawa, M Murata, T Fujikawa, K Katagiri… - PLOS Pathogens, 2023 - cir.nii.ac.jp
抄録< jats: p> A small proportion of human T-cell leukemia virus type-1 (HTLV-1)-infected
individuals develop adult T-cell leukemia/lymphoma, a chemotherapy-resistant …

[PDF][PDF] Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with …

A Hasegawa, M Murata, T Fujikawa, K Katagiri… - PLoS Pathog, 2023 - academia.edu
A small proportion of human T-cell leukemia virus type-1 (HTLV-1)-infected individuals
develop adult T-cell leukemia/lymphoma, a chemotherapy-resistant lymphoproliferative …

Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL …

A Hasegawa, M Murata, T Fujikawa… - PLoS …, 2023 - search.proquest.com
A small proportion of human T-cell leukemia virus type-1 (HTLV-1)-infected individuals
develop adult T-cell leukemia/lymphoma, a chemotherapy-resistant lymphoproliferative …

Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL …

A Hasegawa, M Murata, T Fujikawa, K Katagiri… - 2023 - agris.fao.org
A small proportion of human T-cell leukemia virus type-1 (HTLV-1)-infected individuals
develop adult T-cell leukemia/lymphoma, a chemotherapy-resistant lymphoproliferative …

Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL …

A Hasegawa, M Murata, T Fujikawa, K Katagiri… - Plos …, 2023 - europepmc.org
A small proportion of human T-cell leukemia virus type-1 (HTLV-1)-infected individuals
develop adult T-cell leukemia/lymphoma, a chemotherapy-resistant lymphoproliferative …

Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL …

A Hasegawa, M Murata, T Fujikawa, K Katagiri… - Plos …, 2023 - europepmc.org
A small proportion of human T-cell leukemia virus type-1 (HTLV-1)-infected individuals
develop adult T-cell leukemia/lymphoma, a chemotherapy-resistant lymphoproliferative …